The study of MSC trafficking is clinically relevant for minimally invasive cell therapy to
promote regeneration of damaged tissue, to treat inflammation, and to promote …

Mesenchymal stem cells/marrow stromal cells (MSCs) present a promising tool for cell
therapy, and are currently being tested in US FDA-approved clinical trials for myocardial …

Alzheimer's disease (AD) is characterized by the deposition of amyloid-β peptide (Aβ) and
the formation of neurofibrillary tangles. Transplantation of bone marrow-derived …

Receptor tyrosine kinases play an important role in many cellular processes, and their
dysregulation leads to diseases, most importantly cancer. One such receptor tyrosine kinase …

Recently, mesenchymal stromal cell (MSC)-based therapy has become an appreciated
therapeutic approach in the context of neurodegenerative disease therapy. Accordingly, a …

The therapeutic potential of bone marrow-derived mesenchymal stem cells (BM-MSCs) has
recently been explored in various pathological conditions of the central nervous system …

The neuropathological hallmarks of Alzheimer's disease (AD) include the presence of
extracellular amyloid-β peptide (Aβ) in the form of amyloid plaques in the brain parenchyma …

No long term effective treatments are currently available for brain neurological disorders
such as stroke/cerebral ischemia, traumatic brain injury and neurodegenerative disorders …

Stem cells have been increasingly recognized as a potential tool to replace or support cells
damaged by the neurodegenerative process that underlies Parkinson's disease (PD). In this …

Adult mesenchymal stem cells (MSCs) exhibit neuroprotective properties when introduced
into the degenerating central nervous system through different putative mechanisms …